Search by Drug Name or NDC
NDC 53002-1526-02 Cefdinir 300 mg/1 Details
Cefdinir 300 mg/1
Cefdinir is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is CEFDINIR.
MedlinePlus Drug Summary
Cefdinir is used to treat certain infections caused by bacteria such as bronchitis (infection of the airway tubes leading to the lungs); pneumonia; and infections of the skin, ears, sinuses, throat, and tonsils.. Cefdinir is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Antibiotics such as cefdinir will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 53002-1526-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cefdinir
Product Information
NDC | 53002-1526 |
---|---|
Product ID | 53002-1526_2fee3967-6e6b-422d-9518-86c9f794fd57 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Cefdinir |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Cefdinir |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 300 |
Active Ingredient Units | mg/1 |
Substance Name | CEFDINIR |
Labeler Name | RPK Pharmaceuticals, Inc. |
Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA065434 |
Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1526-02 (53002152602)
NDC Package Code | 53002-1526-2 |
---|---|
Billing NDC | 53002152602 |
Package | 20 CAPSULE in 1 BOTTLE (53002-1526-2) |
Marketing Start Date | 2018-10-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |